Cargando…
Clinical Indications for Treatment with Multi-Kinase Inhibitors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer
SIMPLE SUMMARY: Differentiated thyroid cancer generally has an indolent, slow-growing nature. The disease gradually progresses in some of the patients and can ultimately develop into life-threatening conditions. Multi-kinase inhibitors including sorafenib and lenvatinib demonstrated prolonged progre...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126102/ https://www.ncbi.nlm.nih.gov/pubmed/34068664 http://dx.doi.org/10.3390/cancers13092279 |